LRRK2功能缺失变异在人类中的效应研究
本研究系统分析gnomAD、UK Biobank和23andMe数据库中LRRK2的功能缺失变异,鉴定出1455名高置信度携带者;实验验证三个变异结合既往工作确认82.5%队列蛋白水平降低;杂合功能缺失变异降低LRRK2蛋白水平但未与特定表型或疾病状态强关联。
要点
- LRRK2杂合功能缺失变异降低蛋白水平,未与特定表型或疾病强关联。
- 大规模基因组数据库可用于药物靶点验证。
- LRRK2抑制剂临床开发需关注功能缺失携带者的表型特征。
核心结论
- LRRK2杂合功能缺失变异降低LRRK2蛋白水平,但未与任何特定表型或疾病状态强关联。
研究设计与样本
- 经严格变异 curation 后鉴定出1455名高置信度LRRK2功能缺失变异携带者。
主要发现
- 实验验证三个变异结合既往工作确认82.5%队列蛋白水平降低。
- 杂合功能缺失变异降低LRRK2蛋白水平但未与特定表型或疾病状态强关联。
临床怎么用
- 大规模基因组数据库和功能缺失携带者表型分析可用于药物发现中的靶点验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human genetic variants predicted to cause loss-of-function of protein-coding genes (pLoF variants) provide natural in vivo models of human gene inactivation and can be valuable indicators of gene function and the potential toxicity of therapeutic inhibitors targeting these genes1,2. Gain-of-kinase-function variants in LRRK2 are known to significantly increase the risk of Parkinson's disease3,4, suggesting that inhibition of LRRK2 kinase activity is a promising therapeutic strategy. While preclinical studies in model organisms have raised some on-target toxicity concerns5-8, the biological consequences of LRRK2 inhibition have not been well characterized in humans. Here, we systematically analyze pLoF variants in LRRK2 observed across 141,456 individuals sequenced in the Genome Aggregation Database (gnomAD)9, 49,960 exome-sequenced individuals from the UK Biobank and over 4 million participants in the 23andMe genotyped dataset. After stringent variant curation, we identify 1,455 individuals with high-confidence pLoF variants in LRRK2. Experimental validation of three variants, combined with previous work10, confirmed reduced protein levels in 82.5% of our cohort. We show that heterozygous pLoF variants in LRRK2 reduce LRRK2 protein levels but that these are not strongly associated with any specific phenotype or disease state. Our results demonstrate the value of large-scale genomic databases and phenotyping of human loss-of-function carriers for target validation in drug discovery.
引用
- Whiffin N, Armean IM, Kleinman A, et al. The effect of LRRK2 loss-of-function variants in humans. Nat Med. 2020. PMID: 32461697. doi:10.1038/s41591-020-0893-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。